Newman Yeilding, M.D.
Chief Medical Officer @ Santa Ana Bio, Inc.
About
I am a medical doctor with more than 25 years of clinical and research experience and have contributed to more than 30 scientific publications. I joined the Janssen Pharmaceutical family in September of 2002 and have since worked as a medical researcher conducting and overseeing numerous clinical trials and programs. In my current role, as the Head of Immunology Development at Janssen Research and Development, LLC., I manage a team of approximately 50 physicians, clinical scientists, administrative assistants, and Late Stage Compound Development Leaders across Immunology who oversee clinical development of Immunology assets, including Phase 0-3 Immunology clinical trials.
United States
San Francisco Bay Area
Pharmaceuticals
Biotechnology, Clinical Research, Dermatology, Immunology, Pharmaceutical Industry, Research, Clinical Development, Microsoft Excel, Clinical Trials, PowerPoint, Strategic Planning, Infectious Diseases, Medicine, Healthcare, Hospitals, Oncology, Life Sciences, Cancer, Medical Affairs
Experience

Pharmaceutical Consultant
Independent Consultant

Head of Immunology Development
Lead Immunology Development Team Manage team of approximately 50 physicians, clinical scientists and administrative assistants responsible for Immunology development, including: o Transitional medicine o Rheumatology development o GI and Dermatology development Manage Late Stage Compound Development Team Leaders across Immunology.

Vice President of Immunology, Gastroenterology (GI)/ Dermatology Development Leader
Lead Gastroenterology and Dermatology Development Teams Manage nine physicians and clinical scientists who oversee Phase 2 and 3 GI and Dermatology clinical trials

Senior Director- Vice President of Immunology, Clinical R&D, CDTL
Lead cross-functional strategic compound development team responsible for planning and executing the global development of a biologic compound o Global licensing, launch, commercialization of treatment for psoriasis o Lifecycle planning and development of treatment for the following indications: Psoriatic arthritis, Crohn’s Disease, Pediatric psoriasis, and other lifecycle line extensions Early Stage Biologic Compound Development Team Leader Lead cross-functional team strategic compound development team responsible for one early stage biologic asset

Associate Director – Senior Director, Immunology Development
Centocor, Inc., Janssen Research and Development, LLC
Clinical leader for clinical development of a biologic for psoriasis from the Phase 2b through global Phase 3 program, and Global licensing; Oversight of Pediatric development program Dermatology Clinical Team Leader: Lead cross-functional team responsible for design, execution, and reporting of all Centocor/Janssen dermatology clinical trials

Associate Director of Immunology, Medical Affairs
Centocor, Inc.
Oversight of Medical Affairs Phase 4 trials, Registries, and Investigator Initiated Trials

Assistant Professor, Department of Medicine
University of Pennsylvania

Instructor, Department of Medicine
University of Pennsylvania
Newman Yeilding, M.D.'s Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.






